A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB

Clinical trial NCT04853823 · UNKNOWN

Trial details

NCT number: NCT04853823
Sponsor: Hapten Sciences, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Contact Dermatitis

Start date: 2021-11-01
Primary completion: 2022-11-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.